Literature DB >> 31352536

Stroke Risk in Atrial Fibrillation: Beyond the CHA2DS2-VASc Score.

Pooja S Jagadish1, Rajesh Kabra2.   

Abstract

PURPOSE OF REVIEW: Stroke prevention is the cornerstone of atrial fibrillation (AF) management and the anticoagulation decision is currently based on CHA2DS2-VASc risk score. We discuss several novel risk factors besides those included in CHA2DS2-VASc score and alternative models for stroke prediction. RECENT
FINDINGS: Several clinical markers including obstructive sleep apnea and renal failure, laboratory markers like brain natriuretic peptide, imaging criteria including left atrial appendage morphology, spontaneous echo contrast, and coronary artery calcium score may predict stroke in AF patients. Addition of African American ethnicity to CHA2DS2-VASc score also improves stroke prediction in AF. Finally, novel models including TIMI-AF score, ATRIA score, and GARFIELD-AF scores have potential roles in risk stratification for stroke. While CHA2DS2-VASc score is the currently recommended risk stratification model for stroke prediction in AF, use of additional clinical, laboratory, imaging markers, ethnicity, and novel stroke prediction models may further assist in decision to anticoagulate the AF patient for stroke prevention.

Entities:  

Keywords:  Atrial fibrillation; CHA2DS2-VASc; Race; Stroke

Mesh:

Year:  2019        PMID: 31352536     DOI: 10.1007/s11886-019-1189-6

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  56 in total

1.  The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.

Authors:  Jonas Bjerring Olesen; Christian Torp-Pedersen; Morten Lock Hansen; Gregory Y H Lip
Journal:  Thromb Haemost       Date:  2012-04-03       Impact factor: 5.249

2.  Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF.

Authors:  Jonathan P Piccini; Elizabeth S Fraulo; Jack E Ansell; Gregg C Fonarow; Bernard J Gersh; Alan S Go; Elaine M Hylek; Peter R Kowey; Kenneth W Mahaffey; Laine E Thomas; Melissa H Kong; Renato D Lopes; Roger M Mills; Eric D Peterson
Journal:  Am Heart J       Date:  2011-10       Impact factor: 4.749

3.  Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.

Authors:  Leif Friberg; Mårten Rosenqvist; Gregory Y H Lip
Journal:  Eur Heart J       Date:  2012-01-13       Impact factor: 29.983

4.  Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation.

Authors:  B F Gage; A D Waterman; W Shannon; M Boechler; M W Rich; M J Radford
Journal:  JAMA       Date:  2001-06-13       Impact factor: 56.272

5.  Obstructive sleep apnea as a risk factor for stroke and death.

Authors:  H Klar Yaggi; John Concato; Walter N Kernan; Judith H Lichtman; Lawrence M Brass; Vahid Mohsenin
Journal:  N Engl J Med       Date:  2005-11-10       Impact factor: 91.245

6.  Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort.

Authors:  W D Rosamond; A R Folsom; L E Chambless; C H Wang; P G McGovern; G Howard; L S Copper; E Shahar
Journal:  Stroke       Date:  1999-04       Impact factor: 7.914

7.  Traditional risk factors as the underlying cause of racial disparities in stroke: lessons from the half-full (empty?) glass.

Authors:  George Howard; Mary Cushman; Brett M Kissela; Dawn O Kleindorfer; Leslie A McClure; Monika M Safford; J David Rhodes; Elsayed Z Soliman; Claudia S Moy; Suzanne E Judd; Virginia J Howard
Journal:  Stroke       Date:  2011-09-29       Impact factor: 7.914

Review 8.  Spontaneous echo contrast: where there's smoke there's fire.

Authors:  I W Black
Journal:  Echocardiography       Date:  2000-05       Impact factor: 1.724

9.  Association of atrial fibrillation and obstructive sleep apnea.

Authors:  Apoor S Gami; Gregg Pressman; Sean M Caples; Ravi Kanagala; Joseph J Gard; Diane E Davison; Joseph F Malouf; Naser M Ammash; Paul A Friedman; Virend K Somers
Journal:  Circulation       Date:  2004-07-12       Impact factor: 29.690

10.  Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study.

Authors:  Jonas Bjerring Olesen; Gregory Y H Lip; Morten Lock Hansen; Peter Riis Hansen; Janne Schurmann Tolstrup; Jesper Lindhardsen; Christian Selmer; Ole Ahlehoff; Anne-Marie Schjerning Olsen; Gunnar Hilmar Gislason; Christian Torp-Pedersen
Journal:  BMJ       Date:  2011-01-31
View more
  5 in total

1.  Predicting the Risk of Ischemic Stroke among Patients with Rheumatoid Arthritis Using a Simplified RA-CHADSV Score Based on the CHA2DS2-VASc Score.

Authors:  Chia-Wen Hsu; Khai-Jing Ng; Ming-Chi Lu; Malcolm Koo
Journal:  Medicina (Kaunas)       Date:  2020-02-12       Impact factor: 2.430

2.  Association between lipoprotein(a) and thromboembolism in patients with non-valvular atrial fibrillation: a cross-sectional study.

Authors:  Jie Song; Xiaoxue Zhang; Meng Wei; Yakun Bo; Xianhui Zhou; Baopeng Tang
Journal:  Lipids Health Dis       Date:  2022-08-25       Impact factor: 4.315

3.  Right Atrial Fluorodeoxyglucose Uptake Is a Risk Factor for Stroke and Improves Prediction of Stroke Above the CHA2DS2-VASc Score in Patients With Atrial Fibrillation.

Authors:  Bing Wang; Yiduo Xu; Peng Wan; Shan Shao; Feifei Zhang; Xiaoliang Shao; Jianfeng Wang; Yuetao Wang
Journal:  Front Cardiovasc Med       Date:  2022-07-08

Review 4.  A Review of Biomarkers for Ischemic Stroke Evaluation in Patients With Non-valvular Atrial Fibrillation.

Authors:  Luxiang Shang; Ling Zhang; Yankai Guo; Huaxin Sun; Xiaoxue Zhang; Yakun Bo; Xianhui Zhou; Baopeng Tang
Journal:  Front Cardiovasc Med       Date:  2021-07-01

5.  LDL-C/HDL-C is associated with ischaemic stroke in patients with non-valvular atrial fibrillation: a case-control study.

Authors:  Xiao-Xue Zhang; Meng Wei; Lu-Xiang Shang; Yan-Mei Lu; Ling Zhang; Yao-Dong Li; Jiang-Hua Zhang; Qiang Xing; Zu Kela Tu-Erhong; Bao-Peng Tang; Xian-Hui Zhou
Journal:  Lipids Health Dis       Date:  2020-10-07       Impact factor: 3.876

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.